Medication Insights from Alpha-gal Social Media Groups
top of page

Medication Insights from Alpha-gal Social Media Groups

Alpha-gal syndrome (AGS) is becoming more common, affecting over 450,000 people in the US. It's an allergy triggered by a sugar molecule called α-gal, found in most mammals which can be transmitted from the Lone Star Tick. This allergy is often ignored and makes taking medications tricky because 75% of them have ingredients from animals. What's worse, 75% of AGS patients react to these ingredients, with 50% having severe reactions.


A study presented at the American College of Cardiology 73rd Annual Scientific Session & Expo looked at discussions in social media groups for AGS patients about medication. The goal was to understand how hard it is for these patients to deal with medication.


Unraveling the Medication Conundrum

Patients with AGS are not only vigilant about their dietary choices but also meticulously scrutinize their medication intake. The study revealed that discussions about medications (20%) in AGS social media groups were nearly as prevalent as those about food (22%). Given the prevalence of animal-derived ingredients in medications, transparent labeling is crucial for patients managing AGS.


Insights from the Study

Researchers looked at posts from three AGS support groups on Facebook, which represented 5% of all members. They analyzed 1,195 posts and sorted them into different categories like treatments, symptoms, and medications.


The frequency of drugs mentioned within these groups revealed some noteworthy findings. Diphenhydramine, cetirizine, fexofenadine, and ibuprofen were among the most discussed medications, highlighting the significance of antihistamines and pain relievers in managing AGS-related symptoms. However, what's concerning is the presence of animal-derived ingredients in some of these medications, potentially posing risks to AGS patients.


A Call for Transparent Labeling

The study underscores the high patient burden associated with identifying safe medications for AGS management. Transparent medication labeling, such as indicating certified animal-free products, could significantly alleviate this burden and enhance patient safety.


Conclusion

The study sheds light on medication discussions in AGS social media groups, stressing the need for clear labeling and healthcare provider awareness. Collaboration among academia, healthcare, and advocacy groups like VeganMed, Inc., can address medication challenges. By raising awareness and advocating for transparent labeling, we empower patients and enhance their quality of life.


See the study poster below:


 

Disclaimer: The product and/or information provided on VeganMed is of a general nature and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. We do not lab test the products to confirm that they are free from animal ingredients, and it is possible that the formulation and ingredients could have changed. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or product. The information provided in this post is accurate and up to date as of the date it was written. However, please note that circumstances and facts may change over time, and new information may become available that could alter the accuracy or relevance of the content. We encourage readers to verify and cross-reference any information provided here with trusted sources or consult relevant professionals for the most current and accurate updates.


Looking for certified and verified animal-free products?



Thank you for your awareness and concern for animal-derived ingredients!


As a reminder, please comment on our FDA Citizen Petition, requesting clear labeling of animal-derived ingredients in medications. Together, we can make a difference.


If you have any further questions about ingredients in your medicines and supplements, feel free to reach out to the VeganMed team!


216 views0 comments

Recent Posts

See All
bottom of page